Trials / Completed
CompletedNCT00800540
Circadian Ocular Perfusion Pressure and Ocular Blood Flow
Effects of Topical Hypotensive Drugs on Circadian Ocular Perfusion Pressure and Ocular Blood Flow in Patients With Open-Angle Glaucoma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to compare the short term effects of two intraocular pressure (IOP) lowering medications on ocular perfusion pressure (OPP), ocular blood flow, intraocular pressure, and blood pressure in patients with glaucoma. Ocular perfusion pressure (OPP) is defined as the difference between arterial blood pressure (diastolic and systolic) and intraocular pressure. The primary efficacy assessment is based on diastolic ocular perfusion pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brinzolamide 10 mg/ml/Timolol 5 mg/ml eye drops suspension | Fixed combination ophthalmic suspension |
| DRUG | Brimonidine 20 mg/ml/Timolol 5 mg/ml eye drops solution | Fixed combination ophthalmic solution |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2008-12-02
- Last updated
- 2013-03-22
- Results posted
- 2013-03-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00800540. Inclusion in this directory is not an endorsement.